![Chemistry / Business / Organic chemistry / Combination drugs / Ethers / Amines / Erlotinib / Pfizer / Quinazolines / Teva Pharmaceutical Industries / Atovaquone/proguanil / Novartis Chemistry / Business / Organic chemistry / Combination drugs / Ethers / Amines / Erlotinib / Pfizer / Quinazolines / Teva Pharmaceutical Industries / Atovaquone/proguanil / Novartis](https://www.pdfsearch.io/img/e4b3664b7a9e470f5fc93a457c2a4dfe.jpg) Date: 2016-07-22 09:17:34Chemistry Business Organic chemistry Combination drugs Ethers Amines Erlotinib Pfizer Quinazolines Teva Pharmaceutical Industries Atovaquone/proguanil Novartis | | Marketing authorisations which are recommended for suspension and marketing authorisation applications which do not satisfy the criteria for authorisation as adopted by the CHMP on 21 July 2016Add to Reading ListSource URL: www.ema.europa.euDownload Document from Source Website File Size: 281,50 KBShare Document on Facebook
|